Artiva Biotherapeutics (ARTV) EBIT (2023 - 2024)
Historic EBIT for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$18.3 million.
- Artiva Biotherapeutics' EBIT fell 5260.65% to -$18.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$67.3 million, marking a year-over-year change of. This contributed to the annual value of -$67.3 million for FY2024, which is 11936.68% down from last year.
- As of Q4 2024, Artiva Biotherapeutics' EBIT stood at -$18.3 million, which was down 5260.65% from -$18.3 million recorded in Q3 2024.
- Artiva Biotherapeutics' EBIT's 5-year high stood at $10.8 million during Q3 2023, with a 5-year trough of -$18.3 million in Q3 2024.